Brokerage firms have given a mixed reaction to the shares of drug maker CIPLA Ltd. The pharma company announced its results ...

Join us on the Cipla Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock. Stay in ...

Shares of pharma major Cipla Ltd surged sharply in Thursday's trading session after the US Food and Drug Administration ...

Cipla's strong recovery came after the US Food and Drug Administration concluded inspection at its Goa facility with ...

The uptick in Cipla share price came after the United States Food and Drug Administration (USFDA) on Wednesday classified Goa ...

Cipla Ltd, a major player in the Indian pharmaceutical sector, currently trades at ₹1,418. This price reflects a decrease of ...

Cipla Ltd. shares jumped over 10% in early trading on Thursday after the USFDA classified its Goa facility as a "Voluntary ...

Cipla share price: Cipla Ltd shares fell the most in terms of percentage among all the 50 companies in the NSE Nifty today on ...

Cipla Ltd reported a 15.2% year-on-year increase in consolidated net profit to ₹1,303.53 crore for Q2FY25, with revenue at ₹7 ...

Shares of pharmaceutical giant Cipla dipped 5 per cent at Rs 1,403 per share on the NSE in Wednesday's intraday deals: Cipla ...

Cipla share price had fallen after the company's September quarter results as analysts cut their target price, citing weaker than expected domestic business and challenges in its key products.

Discover the Cipla Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock.